179174-79-9

Basic information

• Product Name: (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid
• Synonyms: (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid;(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoic acid
• CAS NO: 179174-79-9
• Molecular Formula: C₁₉H₁₈O₆S
• Molecular Weight: 374.40762
• EINECS: -0
• Mol File: 179174-79-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid(179174-79-9)
• EPA Substance Registry System: (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid(179174-79-9)

Safety Data

• Hazardous Substances Data: 179174-79-9(Hazardous Substances Data)

Usage

General Description

(Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid is a chemical compound with anti-inflammatory properties. It belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs) and is classified as a COX-2 inhibitor. (Z)-4-acetoxy-3-(4-(Methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid works by inhibiting the production of prostaglandins, which are responsible for causing pain and inflammation in the body. It is commonly used to treat conditions such as arthritis, menstrual cramps, and other types of pain and inflammation. However, it may also present potential side effects and interactions with other drugs, so it should be used under the supervision of a healthcare professional.

Upstream product

• 10049-21-5 sodium dihydrogenphosphate 
• 513-35-9 2-methyl-but-2-ene 
• 87413-09-0 Dess-Martin periodane 
• 179174-77-7 (2Z)-4-hydroxy-2-[4-(methylsulfonyl)phenyl]-3-phenylbut-2-enyl acetate 
• 754242-11-0 (Z)-4-Acetoxy-3-(4-methylsulfanyl-phenyl)-2-phenyl-but-2-enoic acid 

Downstream Products

• 754242-12-1 (Z)-4-Acetoxy-3-(4-methanesulfonyl-phenyl)-2-phenyl-but-2-enoic acid 6-hydroxy-hexyl ester 
• 754242-04-1 6-bromohexyl (2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate 

Relevant articles and documents

Synthesis of a NO-releasing prodrug of rofecoxib

A newly developed synthesis of a NO-releasing prodrug of rofecoxib is described. The highly productive process consists of five chemical steps and produces prodrug 1 in an overall 64% yield from commercially available 3-phenyl-2-propyn-1-ol (4). The synth

Process for making nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors

The invention encompasses a novel process for making compounds of Formula I which are prodrugs of cyclooxygenase-2 selective inhibitors that convert in vivo to diaryl-2-(5H)-furanones and also liberate nitric oxide in vivo. As such, the compounds made by

Stilbene derivatives useful as cyclooxygenase-2 inhibitors

The invention encompasses novel compounds of Formula Iuseful in the treatment of cyclooxygenase-2 mediated diseases. STR1 The invention also encompasses certain pharmaceuticalcompositions and methods for treatment of cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula I.